Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025
Anika (NASDAQ: ANIK) will issue its third quarter 2025 financial results before the market opens on Wednesday, November 5, 2025.
The company will hold a conference call at 8:30 a.m. ET to discuss results and business highlights; dial 1-800-717-1738 (U.S.) or 1-646-307-1865 (international) and use conference ID 53754. A live audio webcast and presentation materials will be available and archived in the Investor Relations section of www.anika.com.
Anika (NASDAQ: ANIK) pubblicherà i risultati finanziari del terzo trimestre 2025 prima dell'apertura del mercato di mercoledì 5 novembre 2025.
L'azienda terrà una conference call alle 8:30 a.m. ET per discutere i risultati e i punti salienti del business; comporre il numero 1-800-717-1738 (USA) o 1-646-307-1865 (internazionale) e utilizzare l'ID conferenza 53754. Una diretta trasmissione audio e i materiali della presentazione saranno disponibili e archiviati nella sezione Relazioni con gli investitori di www.anika.com.
Anika (NASDAQ: ANIK) divulgará sus resultados financieros del tercer trimestre de 2025 antes de la apertura del mercado el miércoles 5 de noviembre de 2025.
La compañía realizará una conferencia telefónica a las 8:30 a.m. ET para discutir los resultados y los aspectos destacados del negocio; marque 1-800-717-1738 (EE. UU.) o 1-646-307-1865 (internacional) y use el ID de conferencia 53754. Una transmisión en vivo de audio y materiales de la presentación estarán disponibles y archivados en la sección de Relaciones con Inversores de www.anika.com.
Anika (NASDAQ: ANIK)는 2025년 3분기 재무 실적을 2025년 11월 5일 수요일 시장 개장 전 발표합니다.
회사는 실적과 사업 하이라이트를 논의하기 위해 동부표준시 기준 8:30 a.m.에 컨퍼런스 콜을 개최합니다; 미국 내 전화는 1-800-717-1738, 국제 전화는 1-646-307-1865로 걸고 컨퍼런스 ID 53754를 사용하십시오. 생방송 오디오 webcast 및 발표 자료는 www.anika.com의 투자자 관계 섹션에서 이용 가능하며 보관됩니다.
Anika (NASDAQ: ANIK) publiera ses résultats financiers du troisième trimestre 2025 avant l'ouverture du marché le mercredi 5 novembre 2025.
La société tiendra une conférence téléphonique à 8 h 30, heure de l'Est pour discuter des résultats et des points saillants de l'activité; composer le 1-800-717-1738 (États-Unis) ou le 1-646-307-1865 (international) et utiliser l'identifiant de conférence 53754. Une diffusion audio en direct et les supports de présentation seront disponibles et archivés dans la section Relations investisseurs de www.anika.com.
Anika (NASDAQ: ANIK) wird seine Finanzergebnisse für das dritte Quartal 2025 vor Börseneröffnung am Mittwoch, den 5. November 2025 bekannt geben.
Das Unternehmen wird eine Telefonkonferenz um 8:30 Uhr ET abhalten, um Ergebnisse und Geschäfts-Highlights zu besprechen; wählen Sie 1-800-717-1738 (USA) oder 1-646-307-1865 (international) und verwenden Sie die Konferenz-ID 53754. Ein Live-Audio-Webcast und Präsentationsmaterialien werden verfügbar sein und im Bereich Investor Relations von www.anika.com archiviert.
Anika (NASDAQ: ANIK) ستصدر نتائجها المالية لل الربع الثالث من 2025 قبل افتتاح السوق يوم الأربعاء 5 نوفمبر 2025.
ستعقد الشركة مكالمة مؤتمرات في 8:30 صباحاً بالتوقيت الشرقي لمناقشة النتائج وأبرز النقاط الأعمال؛ اتصل بالرقم 1-800-717-1738 (الولايات المتحدة) أو 1-646-307-1865 (دولياً) واستخدم معرف المؤتمر 53754. ستكون هناك بث مباشر صوتي ومواد العرض متاحة ومؤرشفة في قسم علاقات المستثمرين على www.anika.com.
Anika (NASDAQ: ANIK) 将会在市场开盘前公布其 2025 年第三季度 财务业绩，时间为 2025 年 11 月 5 日，星期三。
公司将于 美国东部时间 8:30 上午 举行电话会议，讨论业绩和业务亮点；请拨打 1-800-717-1738（美国）或 1-646-307-1865（国际）并使用会议 ID 53754。现场音频网页广播和演示材料将可在 www.anika.com 的投资者关系部分获取并存档。
- None.
- None.
BEDFORD, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its third quarter 2025 financial results before the opening of the market on Wednesday, November 5, 2025, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights.
The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) and providing the conference ID number 53754. A live audio webcast and accompanying presentation materials will be available in the Investor Relations section of Anika's website, www.anika.com. The call will be archived and accessible on the same website shortly after its conclusion.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc. for its use.
For Investor Inquiries:
Anika Therapeutics, Inc.
Matt Hall, 781-457-9554
Director, Corporate Development and Investor Relations
investorrelations@anika.com
FAQ
When will Anika (NASDAQ: ANIK) release Q3 2025 results?
What time is the Anika Q3 2025 conference call and how do I join?
Where can investors find the Anika Q3 2025 webcast and presentation materials?
Will the Anika Q3 2025 conference call be available after the live event?
What topics will Anika cover on the Q3 2025 call for ANIK shareholders?
